Laurie Dee Snyder, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Dept Of Medicine, Durham, NC 27710
Phone (919) 684-2240

Advanced lung disease, lung transplantation, interstitial lung disease, immune monitoring

Education and Training

  • Fellow in Pulmonary Medicine, Medicine, Duke University, 2003 - 2006
  • Medical Resident, Medicine, University of California, San Francisco, School of Medicine, 2000 - 2003
  • M.D., Duke University, 2000

Publications

Gowdy, KM, Nugent, JL, Martinu, T, Potts, E, Snyder, LD, Foster, WM, and Palmer, SM. "Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis." American Journal of Respiratory Cell and Molecular Biology 46, no. 2 (February 2012): 249-256.

PMID
21960548
Full Text

Finlen Copeland, CA, Davis, WA, Snyder, LD, Banks, M, Avery, R, Davis, RD, and Palmer, SM. "Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial." The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation 30, no. 9 (September 2011): 990-996.

PMID
21489817
Full Text

Hartwig, MG, Anderson, DJ, Onaitis, MW, Reddy, S, Snyder, LD, Lin, SS, and Davis, RD. "Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux." The Annals of Thoracic Surgery 92, no. 2 (August 2011): 462-469.

PMID
21801907
Full Text

Martinu, T, Kinnier, CV, Gowdy, KM, Kelly, FL, Snyder, LD, Jiang, D, Foster, WM, Garantziotis, S, Belperio, JA, Noble, PW, and Palmer, SM. "Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3." J Heart Lung Transplant 30, no. 6 (June 2011): 717-725.

PMID
21444213
Full Text

Copeland, CAF, Davis, WA, Snyder, LD, Banks, M, Avery, R, and Palmer, SM. "Reduced Lifetime Incidence of Cytomegalovirus with Extended Prophylaxis: Long-Term Follow Up from a Randomized Controlled Trial." April 2011.

Scholars@Duke

Snyder, LD, Medinas, R, Chan, C, Sparks, S, Davis, WA, Palmer, SM, and Weinhold, KJ. "Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis." Am J Transplant 11, no. 3 (March 2011): 553-560.

PMID
21219584
Full Text

Finlen Copeland, CA, Snyder, LD, Zaas, DW, Turbyfill, WJ, Davis, WA, and Palmer, SM. "Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients." American Journal of Respiratory and Critical Care Medicine 182, no. 6 (September 2010): 784-789.

PMID
20508211
Full Text

Snyder, LD, Finlen-Copeland, CA, Turbyfill, WJ, Howell, D, Willner, DA, and Palmer, SM. "Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation." American Journal of Respiratory and Critical Care Medicine 181, no. 12 (June 2010): 1391-1396.

PMID
20167845
Full Text

Copeland, CF, Kelly, FL, Snyder, LD, and Palmer, SM. "Clinical And Genetic Predictors Of Pulmonary Aspergillus Infection, A Major Risk Factor For Bronchiolitis Obliterans Syndrome After Lung Transplantation." AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 181 (2010).

Scholars@Duke

Snyder, LD, Dick, T, Davis, WA, Chen, D, Reams, B, Palmer, SM, and Zaas, DW. "Rituximab For The Treatment Of Humoral Rejection After Human Lung Transplant." AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 181 (2010).

Scholars@Duke

Pages